NCT06360588 2026-03-19
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
NRG Oncology
Mayo Clinic
Mayo Clinic
SWOG Cancer Research Network
Roswell Park Cancer Institute
Thomas Jefferson University
Emory University